Featured Research

from universities, journals, and other organizations

Vaccinations of US children declined after publication of now-refuted autism risk

Date:
June 4, 2012
Source:
University of Cincinnati
Summary:
Health economics researchers have found that publication of the perceived risk linking the MMR (measles, mumps, rubella) vaccine to autism in the late 1990s seemingly led to declines in the vaccination rate of children. This is despite the fact that later studies refuted the existence of an MMR-autism link.

New University of Cincinnati research has found that fewer parents in the United States vaccinated their children in the wake of concerns about a purported link (now widely discredited) between the MMR (measles, mumps, rubella) vaccine and autism.

Lenisa Chang, assistant professor of economics in UC's Carl H. Lindner College of Business, found that the MMR-autism controversy, which played out prominently in the popular media following publication in a 1998 medical journal, led to a decline of about two percentage points in terms of parents obtaining the MMR vaccine for their children in 1999 and 2000. And even after later studies thoroughly refuted the alleged MMR-autism link, the drop off in vaccination rates persisted.

For her study, "The MMR-Autism Controversy: Did Autism Concerns Affect Vaccine Take Up?" to be presented during the 4th Biennial Conference of the American Society of Health Economics June 10-13 in Minnesota, Chang examined data from the National Immunization Survey from 1995 through 2006 to gauge parents' response toward the vaccine-autism controversy.

Interestingly, in the aftermath of the controversy, Chang found that the higher a mother's education level, the less likely a child was to receive an MMR vaccination. In other words, college-educated mothers were less likely to have their children vaccinated than were non-college education mothers. This may be due to the fact that more educated mothers have better access and/or more quickly absorb medical information available in the media.

After epidemiological studies refuted the MMR-autism link, the difference in MMR usage by mother's education level persisted and became more pronounced in 2003, 2004 and 2006, possibly as previous negative information received more weight than positive information in the parental decision-making process on whether or not to vaccinate.

She also found that the controversy, begun with the publication of research (later discredited) linking the MMR vaccine to risks for autism in "The Lancet" medical journal, seemingly had a spillover effect to other vaccines -- such as polio or other measles-containing vaccines -- likely as a result of concern for safety over the MMR controversy.

Chang says the decline is a significant decrease and attributes the spillover effect to parental concerns.

"The spillover effect I find on other vaccines such as polio and, to a lesser degree DTP (diphtheria, tetanus and pertussis), could be partially ascribed to general safety concerns toward all vaccines that stemmed from the MMR controversy, but other factors might be at play as well," Chang says.

In other related work, Chang is researching the effect on immunization rates of state mandates that require insurance companies to cover childhood vaccines.


Story Source:

The above story is based on materials provided by University of Cincinnati. The original article was written by Judy Ashton. Note: Materials may be edited for content and length.


Cite This Page:

University of Cincinnati. "Vaccinations of US children declined after publication of now-refuted autism risk." ScienceDaily. ScienceDaily, 4 June 2012. <www.sciencedaily.com/releases/2012/06/120604142726.htm>.
University of Cincinnati. (2012, June 4). Vaccinations of US children declined after publication of now-refuted autism risk. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2012/06/120604142726.htm
University of Cincinnati. "Vaccinations of US children declined after publication of now-refuted autism risk." ScienceDaily. www.sciencedaily.com/releases/2012/06/120604142726.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins